MIT’s Koch Institute in strategic partnership with Ortho-McNeil-Janssen Pharmaceuticals
Organizations will collaborate in multiple areas of oncology research and technology development.
An easier way to synthesize new drug candidates
MIT chemists’ answer to long-standing problem could have a big impact on pharmaceutical business.
Why cancer drugs lose their power
MIT biologists show how tumors can become resistant to the commonly used chemotherapy drug cisplatin.
Biomanufacturing Research Program wins grant from Sloan Foundation
Will be used to examine globalization and regulatory compliance
